Atsuhiro Ichihara Selected Research

Atsuhiro Ichihara Research Topics

Disease

33	Hypertension (High Blood Pressure) 01/2022 - 05/2006
15	Hyperaldosteronism (Conn Syndrome) 08/2022 - 04/2012
9	Proteinuria 08/2022 - 09/2006
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2008
9	Inflammation (Inflammations) 09/2019 - 06/2006
9	Diabetic Nephropathies (Diabetic Nephropathy) 11/2014 - 06/2003
6	Essential Hypertension 01/2017 - 06/2008
5	Neoplasms (Cancer) 01/2022 - 01/2007
5	Fibrosis (Cirrhosis) 01/2020 - 05/2006
5	Chronic Renal Insufficiency 06/2018 - 01/2009
4	Arteriosclerosis 10/2022 - 11/2008
4	Pre-Eclampsia (Preeclampsia) 08/2022 - 01/2016
4	Diabetes Mellitus 01/2020 - 12/2013
4	Albuminuria 01/2011 - 12/2009
3	Adenoma (Adenomas) 06/2021 - 12/2019
3	Hypoxia (Hypoxemia) 01/2020 - 03/2018
3	Heart Failure 01/2020 - 07/2010
3	Paraganglioma (Paragangliomas) 12/2019 - 04/2013
3	Pheochromocytoma 12/2019 - 04/2013
3	Edema (Dropsy) 01/2018 - 11/2004
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 09/2008
3	Insulin Resistance 01/2016 - 09/2009
3	Type 2 Diabetes Mellitus (MODY) 12/2014 - 08/2002
3	Renal Insufficiency (Renal Failure) 12/2011 - 11/2008
3	Stroke (Strokes) 01/2008 - 05/2006
3	AIDS-Related Complex (ARC) 11/2003 - 02/2002
2	Osteoporosis 10/2022 - 01/2015
2	Cushing Syndrome 10/2022 - 01/2019
2	Graves Disease (Basedow Disease) 05/2021 - 01/2018
2	Gynecomastia 01/2021 - 12/2019
2	Hypopituitarism (Sheehan's Syndrome) 01/2020 - 01/2018
2	Choroidal Neovascularization 09/2019 - 12/2008
2	Macular Degeneration (Age-Related Maculopathy) 09/2019 - 12/2008
2	Obesity 03/2018 - 01/2014
2	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2018 - 01/2017
2	Atherosclerosis 01/2016 - 08/2010
2	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2014 - 06/2013
2	Hyperglycemia 11/2014 - 10/2004
2	Body Weight (Weight, Body) 01/2014 - 01/2014
2	Sepsis (Septicemia) 01/2014 - 10/2000
2	Dyslipidemias (Dyslipidemia) 01/2013 - 05/2005
2	Hypercholesterolemia 01/2013 - 03/2012
2	Uveitis 01/2007 - 06/2006
1	Atrophy 01/2022
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2022

Drug/Important Bio-Agent (IBA)

44	Prorenin ReceptorIBA 01/2020 - 05/2006
32	ReninIBA 01/2022 - 02/2002
14	Peptides (Polypeptides)IBA 01/2011 - 10/2004
9	AldosteroneIBA 06/2021 - 04/2012
8	SaltsIBA 11/2020 - 11/2004
6	Angiotensin IIIBA 02/2014 - 06/2007
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2008
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2007
5	Small Interfering RNA (siRNA)IBA 01/2020 - 03/2015
5	Streptozocin (Streptozotocin)FDA Link 09/2008 - 06/2003
4	esaxerenoneIBA 08/2022 - 01/2021
4	Antihypertensive Agents (Antihypertensives)IBA 10/2020 - 08/2010
4	CatecholaminesIBA 01/2020 - 12/2014
4	AngiotensinsIBA 12/2017 - 11/2003
3	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 10/2002
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 01/2020
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 06/2007
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2008
3	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2019 - 07/2016
3	SodiumIBA 12/2017 - 05/2010
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2014 - 08/2010
3	Fluvastatin FDA Link 01/2013 - 08/2002
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2022 - 01/2019
2	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2022
2	Growth Hormone (Somatotropin)IBA 01/2022 - 03/2018
2	Angiotensin Receptor AntagonistsIBA 10/2020 - 01/2011
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020 - 12/2007
2	CholesterolIBA 01/2020 - 01/2007
2	alpha-Methyltyrosine (Metirosine)FDA Link 12/2019 - 03/2018
2	AlbuminsIBA 12/2019 - 12/2014
2	CateninsIBA 10/2019 - 03/2015
2	GlucocorticoidsIBA 01/2019 - 01/2017
2	Amlodipine (Norvasc)FDA LinkGeneric 06/2018 - 01/2009
2	aliskiren FDA Link 06/2018 - 05/2010
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 03/2012
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 12/2014
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2014 - 01/2014
2	LipidsIBA 03/2012 - 08/2002
2	FructoseIBA 01/2011 - 09/2009
2	candesartanIBA 08/2010 - 11/2003
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 12/2009 - 01/2009
2	Retinaldehyde (Retinal)IBA 07/2009 - 05/2008
2	Messenger RNA (mRNA)IBA 01/2009 - 05/2006
2	Type 1 Angiotensin ReceptorIBA 12/2008 - 05/2008
2	EndotoxinsIBA 01/2007 - 06/2006
1	Nifedipine (Adalat)FDA LinkGeneric 08/2022
1	growth hormone-releasing peptide-2 (KP 102)IBA 01/2022
1	Androgen Antagonists (Antiandrogens)IBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022

Therapy/Procedure

19	Therapeutics 05/2021 - 08/2004
10	Renal Dialysis (Hemodialysis) 01/2021 - 05/2005
2	Kidney Transplantation 01/2021 - 05/2018
2	Radiotherapy 12/2020 - 01/2020
2	Adrenalectomy 05/2018 - 12/2017
2	Nephrectomy 05/2010 - 01/2007